A 75‐year‐old man was referred to our centre with a history of sudden onset painless loss of vision in the right eye, on a background of recent jaw claudication and weight loss. The visual loss developed suddenly 5 days before presentation. His medical history included hypertension, hyperlipidaemia, prior ischaemic stroke, and a 40‐pack‐year smoking history.
The full article is accessible to AMA members and paid subscribers. Login to read more or purchase a subscription now.
Please note: institutional and Research4Life access to the MJA is now provided through Wiley Online Library.
- 1. Varma DD, Cugati S, Lee AW, Chen CS. A review of central retinal artery occlusion: clinical presentation and management. Eye (Lond) 2013; 27: 688–697.
- 2. Hayreh SS, Zimmerman MB. Central retinal artery occlusion: visual outcome. Am J Ophthalmol 2005; 140: 376–391.
- 3. Langabeer SE. The JAK2 V617F mutation in retinal vein or artery occlusion. EXCLI J 2019; 18: 127–128.
- 4. Rumi E, Cazzola M. Diagnosis, risk stratification, and response evaluation in classical myeloproliferative neoplasms. Blood 2017; 129: 680–692.
- 5. Forsyth C, Melville K, Tiley C. The delayed diagnosis of myeloproliferative neoplasms is common and results in a high incidence of potentially preventable thrombotic complications. Pathology 2018; 50: 775–776.
- 6. Barbui T, Carobbio A, Cervantes F, et al. Thrombosis in primary myelofibrosis: incidence and risk factors. Blood 2010; 115: 778–782.
- 7. Parikh M, Miller NR, Lee AG, et al. Prevalence of a normal C‐reactive protein with an elevated erythrocyte sedimentation rate in biopsy‐proven giant cell arteritis. Ophthalmology 2006; 113: 1842–1845.
- 8. Hayreh SS, Podhajsky PA, Raman R, Zimmerman B. Giant cell arteritis: validity and reliability of various diagnostic criteria. Am J Ophthalmol 1997; 123: 285–296.
We thank Alan Hoare, from the Royal Adelaide Hospital, for his help in arranging the fundus image for this manuscript.
No relevant disclosures.